English
Chemotherapy for Malignant Solid Tumours in Bhubaneswar

Chemotherapy for Malignant Solid Tumours and Malignant Blood Diseases

Chemotherapy for Malignant Solid Tumours in Bhubaneswar

Chemotherapy is a systemic treatment that targets rapidly developing cancer cells throughout the body to treat malignant blood disorders and solid tumours. In Chemotherapy for Malignant Solid tumours in Bhubaneswar, strong pharmaceuticals called cytotoxic chemicals are administered. These drugs impede the development and division of cancer cells, which eventually results in their demise.

Chemotherapy is generally the first line of treatment for malignant blood disorders, such as multiple myeloma, lymphoma, and leukaemia. However, it can also harm healthy cells in the body in addition to destroying cancer cells, which can result in side effects such as hair loss, nausea, exhaustion, and an increased risk of infections. To control these adverse effects and enhance the comfort and well-being of patients, supportive care strategies, such as medication and lifestyle changes, are frequently used. 

 

Experience world-class healthcare at Manipal Hospitals. Our expert team of doctors and state-of-the-art facilities ensure personalized and advanced treatments. Take the first step towards wellness. Book an appointment today.

FAQ's

Chemotherapy plays a crucial role in the treatment of malignant solid tumours by either eliminating or impeding the growth of cancer cells. It can be used as the main course of treatment, in conjunction with or after surgery to reduce the size of the tumour, as adjuvant therapy to prevent recurrence, as neoadjuvant therapy to aid surgical removal, or as palliative care in late cases to improve quality of life. Chemotherapy plays a critical role in the comprehensive care of solid tumours, catering to the specific cancer kinds, stages, and patient requirements. It provides curative, adjuvant, neoadjuvant, and palliative advantages.

To achieve either therapeutic or palliative effects, Chemotherapy for malignant solid tumours predominantly targets rapidly proliferating cancer cells inside localised or metastatic tumours. On the other hand, malignant blood disorders such as multiple myeloma, leukaemia, and lymphoma include aberrant multiplication of blood cells, hence requiring systemic medicines to target cancerous cells throughout the body. Blood disorders are typically treated with induction, consolidation, and maintenance treatments; in rare circumstances, Hematopoietic Stem Cell Transplantation may be necessary. Chemotherapy is still essential, based on the patient's needs and the kind, stage, and behaviour of the disease.

Breast cancer, lung cancer, colorectal cancer, ovarian cancer, prostate cancer, pancreatic cancer, lymphoma, and brain tumours are among the common malignant solid tumour types that are treated with Chemotherapy. Chemotherapy has several functions in different types of cancer, including shrinking tumour size, getting rid of cancer cells, and stopping recurrence. Chemotherapy is an essential component of the overall care of many diseases, contributing to better outcomes and longer lifetimes, whether it is used as the main treatment or in combination with other modalities like surgery or radiation therapy.

A key component of the management of malignant blood disorders, including lymphoma and leukaemia, is Chemotherapy. Its methodical medication delivery targets and destroys malignant cells all over the body intending to cause remission, curing any remaining illness, and preventing recurrence. It is essential for bringing leukaemia into remission by removing cancerous cells from the bone marrow and peripheral circulation. Similarly, Chemotherapy targets malignant cells within lymph nodes and tissues in lymphomas. It is frequently used in conjunction with Immunotherapy or Radiation Treatment. In high-risk instances, Chemotherapy also helps patients get ready for Hematopoietic Stem Cell Transplantation, which can improve results and lead to long-term remission.

Many factors play a role in the selection of Chemotherapy regimens for malignant solid tumours. These include medication toxicity, involvement in clinical trials, cancer kind and stage, tumour features, general health of the patient, treatment objectives, and prior therapies. Careful evaluation of these variables is necessary to customise care to each patient's requirements and maximise results. This all-encompassing strategy guarantees that Chemotherapy is precisely targeted and weighed against any advantages and disadvantages.

 
 

 

Chemotherapy for malignant solid tumours and blood diseases often causes side effects due to its impact on rapidly dividing cells. Common side effects include nausea, vomiting, hair loss, fatigue, anaemia, increased infection risk, easy bruising and bleeding, mouth sores, and digestive issues like diarrhoea or constipation. Peripheral neuropathy and organ toxicity (heart, liver, kidneys) can also occur. The severity and type of side effects vary based on the specific drugs used and individual patient factors.

Chemotherapy for malignant solid tumours can be delivered via intraperitoneal or intrathecal delivery, intramuscular or subcutaneous injection, oral administration, or a combination of these routes. Usually, treatment is administered in 1-4-week cycles, with rest intervals in between. The length and regimen of a full course can vary depending on the kind of cancer and the patient's response, sometimes lasting several months. Frequent evaluations guarantee the efficacy of the treatment and enable necessary modifications.

For certain malignant blood disorders, such as some types of leukaemia and lymphoma, Chemotherapy can be administered as a stand-alone treatment, particularly in the early stages, to induce remission. To boost efficacy and increase results, it is frequently used with other therapeutic techniques. Chemotherapy, for example, may be used in conjunction with Radiation Treatment, Immunotherapy, Targeted Therapy, or Hematopoietic Stem Cell Transplantation (HSCT). The combination strategy is customised based on the particular blood disease type, stage, and patient characteristics.

Home Bhubaneswar Specialities Medical-oncology Chemotherapy-for-malignant-solid-tumours-and-malignant-blood-diseases-2

Appointment
Health Check
Contact Us
review icon
Review Us
Call Us